SAN

76.17

-0.67%↓

ARGX

766.4

-2.39%↓

SHL.DE

35.29

+1.41%↑

PHIA

23.26

+2.29%↑

FRE

38.54

+2.34%↑

SAN

76.17

-0.67%↓

ARGX

766.4

-2.39%↓

SHL.DE

35.29

+1.41%↑

PHIA

23.26

+2.29%↑

FRE

38.54

+2.34%↑

SAN

76.17

-0.67%↓

ARGX

766.4

-2.39%↓

SHL.DE

35.29

+1.41%↑

PHIA

23.26

+2.29%↑

FRE

38.54

+2.34%↑

SAN

76.17

-0.67%↓

ARGX

766.4

-2.39%↓

SHL.DE

35.29

+1.41%↑

PHIA

23.26

+2.29%↑

FRE

38.54

+2.34%↑

SAN

76.17

-0.67%↓

ARGX

766.4

-2.39%↓

SHL.DE

35.29

+1.41%↑

PHIA

23.26

+2.29%↑

FRE

38.54

+2.34%↑

Search

Fagron

Open

SectorHealthcare

24.45 -1.21

Overview

Share price change

24h

Current

Min

24.4

Max

24.85

Key metrics

By Trading Economics

Income

-99K

45M

Sales

-98K

476M

P/E

Sector Avg

19.194

49.052

Dividend yield

1.69

Profit margin

9.55

Employees

4,193

EBITDA

11M

98M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+20.59% upside

Dividends

By Acuity

Dividend yield

Sector Avg

1.69%

2.36%

Next Earnings

30 lip 2026

Market Stats

By TradingEconomics

Market Cap

116M

1.7B

Previous open

25.66

Previous close

24.45

News Sentiment

By Acuity

50%

50%

146 / 342 Ranking in Healthcare

Fagron Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

About Fagron

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
help-icon Live chat